Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of Autonomix Medical, Inc. from 31 Mar 2022 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Autonomix Medical, Inc. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 31 Mar 2022 to 31 Dec 2023.
  • Autonomix Medical, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 31 Dec 2023 was $1,218,000, a 50% increase year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Autonomix Medical, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $1,218,000 +$408,000 +50% 31 Dec 2023 10-Q 13 Feb 2024 2024 Q3
Q1 2023 $865,000 -$1,179,000 -58% 31 Mar 2023 10-Q 13 Feb 2024 2024 Q3
Q4 2022 $810,000 31 Dec 2022 10-Q 13 Feb 2024 2024 Q3
Q1 2022 $2,044,000 31 Mar 2022 10-Q 13 Feb 2024 2024 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.